QUILT-2.015: A Study of AMG 479 With Exemestane or Fulvestrant in Postmenopausal Women With Hormone Receptor Positive Locally Advanced or Metastatic Breast Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

156

Participants

Timeline

Start Date

March 27, 2008

Primary Completion Date

May 5, 2010

Study Completion Date

September 23, 2011

Conditions
Breast CancerBreast TumorsMetastatic Cancer
Interventions
DRUG

AMG 479

AMG 479 administered with exemestane or fulvestrant

DRUG

Placebo

Placebo administered with either exemestane or fulvestrant

Trial Locations (60)

4

Research Site, Dublin

8

Research Site, Dublin

2298

Research Site, Waratah

3011

Research Site, Footscray

3144

Research Site, Malvern

3220

Research Site, Geelong

5011

Research Site, Woodville South

6000

Research Site, Lucerne

7000

Research Site, Chur

8032

Research Site, Zurich

15213

Research Site, Pittsburgh

17033

Research Site, Hershey

21079

Research Site, Dijon

27262

Research Site, High Point

28040

Research Site, Madrid

30060

Research Site, Marietta

30177

Research Site, Hanover

30309

Research Site, Atlanta

32605

Research Site, Gainesville

33065

Research Site, Coral Springs

33428

Research Site, Boca Raton

33435

Research Site, Boynton Beach

33467

Research Site, Lake Worth

34298

Research Site, Montpellier

38120

Research Site, Memphis

44800

Research Site, Saint-Herblain

51056

Research Site, Reims

60590

Research Site, Frankfurt

60637

Research Site, Chicago

65929

Research Site, Frankfurt

69008

Research Site, Lyon

72000

Research Site, Le Mans

75248

Research Site, Paris

80637

Research Site, Munich

84003

Research Site, American Fork

85224

Research Site, Chandler

90211

Research Site, Beverly Hills

90640

Research Site, Montebello

91010

Research Site, Duarte

91342

Research Site, Sylmar

92801

Research Site, Anaheim

94115

Research Site, San Francisco

94520

Research Site, Concord

98405

Research Site, Tacoma

06902

Research Site, Stamford

03756

Research Site, Lebanon

07834

Research Site, Denville

V5Z 4E6

Research Site, Vancouver

K1H 8L6

Research Site, Ottawa

P6B 0A8

Research Site, Sault Ste. Marie

M5G 2M9

Research Site, Toronto

H1T 2M4

Research Site, Montreal

06182

Research Site, Nice

08003

Research Site, Barcelona

08907

Research Site, L'Hospitalet de Llobregat

08208

Research Site, Sabadell

DE22 3DT

Research Site, Derby

W6 8RF

Research Site, London

M20 4BX

Research Site, Manchester

PE3 9GZ

Research Site, Peterborough

Sponsors

Lead Sponsor

All Listed Sponsors
lead

NantCell, Inc.

INDUSTRY

NCT00626106 - QUILT-2.015: A Study of AMG 479 With Exemestane or Fulvestrant in Postmenopausal Women With Hormone Receptor Positive Locally Advanced or Metastatic Breast Cancer | Biotech Hunter | Biotech Hunter